Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Cassie Taylor is just getting queerer and weirder (and thanks to a wild 72 hours, she’s now a Playboy Bunny)
Be your authentic self, said Cassie Taylor, even if that means losing people along the way. “The biggest thing I’ve learned in the music industry is that if you’re not authentic, it is not sustainable — you’ll burn out fast. During the pandemic, I lost a lot of friends because I was very vocal about…
Pitch contest winners salute PHKC as fourth cohort wraps; $15K in prizes awarded to small businesses
A winning night at The Porter House KC’s pitch event this week expands opportunity for more than just the company taking home the biggest check, said Taylor Burris. AI Hub — led by Burris and her husband, James Spikes — earned first place and $8,000 in the competition, which also marked the completion of PHKC’s…
KCRise Fund closes $34M Fund III with ‘hyper-local’ focus; Here are its first four investments
A third venture capital fund — expected to invest $34 million in 20 more tech startups across the Kansas City region — builds on KCRise Fund’s thesis that high-growth local companies are the key to investor success, said Ed Frindt. It’s a competitive advantage that swells with each wave of funding, he added, announcing the…
These makers and vendors aren’t buying the scarcity mindset: ‘There’s a way for us all to eat’
A new vendor fair aims to unite people from all corners of the city and promote collaboration among the local vendor community, said entrepreneur and event organizer Dontavious Young. “I see a lot of events in Kansas City that are geared toward a specific type of crowd, or a specific type of culture, or a…